BUY MBP GRANULOCYTE COLONY STIMULATING FACTOR GLENSTIM PEG 6MG VIAL BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Glenstim PEG 6 mg is a long-acting form of pegfilgrastim, a medication used to reduce the risk of infection in patients receiving chemotherapy. It belongs to a group of medicines called granulocyte colony-stimulating factors (G-CSF). Glenstim PEG helps the body produce more white blood cells, particularly neutrophils, which are essential for fighting infections.

Chemotherapy often reduces the number of white blood cells in the body, a condition known as neutropenia. When neutrophil levels are low, the body becomes highly vulnerable to infections, which can be severe or life-threatening. Glenstim PEG works by stimulating the bone marrow to produce and release more neutrophils into the bloodstream, helping the immune system recover more quickly after chemotherapy.

Glenstim PEG is given as a single injection under the skin, usually once per chemotherapy cycle. It is typically administered at least 24 hours after chemotherapy and not on the same day as chemotherapy. Because it is long-acting, one injection usually lasts until the next treatment cycle, making it more convenient than daily injections of similar medicines.

After administration, Glenstim PEG slowly releases pegfilgrastim into the bloodstream. It continues to stimulate white blood cell production until neutrophil levels return to normal. Once recovery occurs, the drug is naturally cleared from the body.

Common side effects of Glenstim PEG include bone pain, muscle pain, joint pain, and general body aches. This happens because the bone marrow becomes more active in producing white blood cells. The pain is usually mild to moderate and can often be managed with simple pain relief such as paracetamol, unless otherwise advised by a healthcare provider.

Other possible side effects include headache, fatigue, nausea, and mild swelling or redness at the injection site. These effects are usually temporary and improve on their own.

Less commonly, Glenstim PEG may cause enlargement of the spleen, which can present as pain in the upper left side of the abdomen or shoulder. In very rare cases, the spleen may rupture, which is a medical emergency. Any sudden or severe abdominal or shoulder pain should be reported immediately.

Another rare but serious side effect is acute respiratory distress syndrome, which may cause shortness of breath, cough, or breathing difficulty. Immediate medical attention is required if these symptoms occur.

Glenstim PEG should be used with caution in patients with sickle cell disease, as it may trigger a sickle cell crisis. It should also be used carefully in people with a history of allergic reactions to pegfilgrastim or similar medicines.

This medication is not a treatment for cancer itself but is used to support chemotherapy by reducing the risk of infection, hospitalisation, and treatment delays. By maintaining adequate white blood cell levels, Glenstim PEG helps patients stay on schedule with their cancer treatment.

Patients receiving Glenstim PEG should be monitored with regular blood tests to assess white blood cell response. Any unusual symptoms such as persistent fever, bone pain, breathing difficulty, or signs of infection should be reported promptly.

When used appropriately under medical supervision, Glenstim PEG is a highly effective and important supportive therapy that improves safety and outcomes for patients undergoing chemotherapy.